Skip to main content
Clinical Trials/CTRI/2020/02/023410
CTRI/2020/02/023410
Not Yet Recruiting
Phase 4

A Clinical Study To Evaluate The Therapeutic Effect Of Shubhdeep Liv-Gud Pill In The Management Of Yakrutdalyodara W.S.R to Fatty Liver Disease.

Shubhdeep Ayurveda Medical College And Hospital0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified
Sponsor
Shubhdeep Ayurveda Medical College And Hospital
Status
Not Yet Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Shubhdeep Ayurveda Medical College And Hospital

Eligibility Criteria

Inclusion Criteria

  • 1\. Patient presenting with clinical feature of yakrutdalyodara(Fatty liver).
  • 2\. Patient with or without the clinical feature of yakrutdalyodara, diagnosed to be having USG whole abdomen where include for the study.
  • 3\. Patient age between 20\-60 years with either sex.
  • 4\. Patient of alcoholic addiction, obesity, type\-2 diabetes mellitus.

Exclusion Criteria

  • 1\. Patient aged less than 20 yr and more than 60 years.
  • 2\. Patient with hepatic encephalopathy, systemic multiorgan syndrom, malignency of liver and cirrhosis of liver and prehepatic and hepatic coma, bleeding disorder, etc.
  • 3\. Pregnent women.
  • 4\. Hepatitis B and C.
  • 5\. Patient on steroid treatment.

Outcomes

Primary Outcomes

Not specified

Similar Trials